David Schmickel, JD, PhD

SENIOR COUNSEL, REGULATORY & INTELLIGENCE STRATEGY

Dave Schmickel brings over 25 years of biotechnology industry experience to Adjuvant Partners. Prior to working with Adjuvant, Dave was a partner at the Washington DC based firm Foxkiser where he helped launch companies, counseled biotech and pharmaceutical companies on regulatory, reimbursement and life-cycle strategies. Dave's practice focused on novel approval strategies for clinically important drugs and biologics in the US and around the world.

Prior to working with Adjuvant, Dave also worked on the US Senate Health Education Labor and Pensions committee on FDA, NIH, and biodefense policy issues and at BIO where he established the Intellectual Property Committee at BIO's founding.

Dave earned his bachelor of science from University of Maryland, his juris doctorate at the University of Baltimore and his doctorate from Johns Hopkins University.